Drugs / TCM-700C
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00556504 | Jul 2007 → Jan 2011 | chronic hepatitis C virus infection | TCM Biotech International Corp. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01890200 | Jun 2015 → Mar 2018 | chronic hepatitis C virus infection | TCM Biotech International Corp. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TCM-700C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00556504 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a Chinese formulation (TCM-700C)” NCT00556504 ↗ |